First Pharmaceutical (600833.SH) announced semi-annual results, with net profit of 26.1698 million yuan to mother, an increase of 86.6% over the previous year

Zhitong Finance App News, First Pharmaceutical (600833.SH) released its 2026 semi-annual report. During the reporting period, the company achieved operating income of 982 million yuan, a year-on-year decrease of 1.51%; net profit attributable to shareholders of listed companies was 26.1698 million yuan, an increase of 86.6% year on year; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss was 1,31119 million yuan, a year-on-year decrease of 85.44%; basic earnings per share were 0.1,173 yuan.

During the reporting period, the year-on-year increase in the company's total profit, net profit attributable to shareholders of listed companies, basic earnings per share, and diluted earnings per share was mainly due to subsidiaries receiving housing expropriation compensation during the reporting period; net profit attributable to shareholders of listed companies after deducting non-recurring profit and loss, and the year-on-year decline in basic earnings per share after deducting non-recurring profit and loss was mainly due to increased competition in the pharmaceutical distribution industry under the influence of the policy and market environment. The company's opening of new stores in recent years has had an impact on profits in the short term.